Hawk70 say we remove the drug completely from the portfolio of NYR because the drug magically disappeared and NYR had nothing but their funding position, the market cap is their funding position right now lol that’s how dumb this share price is that’s it’s not only pricing in no potential but also below CEO and director shares coming in this week on Thursday.
If they want they can announce they have acquired a REE tenement in WA and the share price will be 300-400 percent up in a day with that funding position lol. Any biotech with this cash position and the potential from a drug like this on multiple preclinical study successes should be well above a 50 million market cap and on phase 1 a 70-100 million market cap. This is not a 10 million dollar valuation
Hawk70 say we remove the drug completely from the portfolio of...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
-0.001(1.59%) |
Mkt cap ! $11.12M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.5¢ | 6.2¢ | $3.61K | 56.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 80 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
-0.001 ( 1.56 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.3¢ | 6.3¢ | 43043 | ||
| Last updated 15.09pm 24/05/2024 ? | |||||
| NYR (ASX) Chart |